If you liked this article you might like

Bayer's Strong Second-Quarter Figures Make Weak Case for Higher Monsanto Bid
Bayer Quarterly Earnings Top Forecasts as New Drug Sales Steal Limelight
BASF Quarterly Sales, Profit Miss Forecast
Syngenta Reports 'Constructive' Talks With Regulators as First Half Lags Forecasts